Edmund Waller is a Hematology physician affiliated with Emory University. OpenAlex indexes 909 publications with 27,875 citations (h-index 84); ClinicalTrials.gov lists 3 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Hematology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1365 Clifton Rd NE
Atlanta, GA 303221013
Telephone
404-778-1900Registry record last updated 8 Jul 2007.
Clinical trials
- Bone Marrow and Peripheral Blood Immune Responses Study
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20259 payments$28,793openpaymentsdata.cms.gov ↗
- Incyte CorporationProgram year202511 payments
- SANOFI-AVENTIS U.S. LLCProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
54.5%Selective immunosuppressants30.3%Rezurock100%Part D≥11 patientsKinase inhibitor19.7%Brukinsa46%Jakafi33%Sirolimus21%Part D<11 patients+ 1 more class in this area
Anti-infectives
28%Cytomegalovirus DNA Terminase Complex Inhibitor12.5%Prevymis100%Part D<11 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor11%Valacyclovir100%Part D<11 patients+ 1 more class in this area
Dermatology
17.4%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor17.4%Acyclovir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
13 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- Development of a Novel Immunotherapeutic for Acute Myeloid Leukemia
Cambium Oncology Llc
FY2026$1,050,003R44CA285206 - Leveraging CD26high Meso-CAR T cells in patients with advanced pancreatic cancer
Emory University
FY2026$638,929R01CA287866 - Targeting VIP–VPAC Signaling to Reverse Immune Exclusion and Enhance Immunotherapy Response in Pancreatic Cancer
Emory University
FY2026$636,358R01CA314282
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>
Journal of Clinical Oncology
2024 - Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Journal of Clinical Oncology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Guyton, MD
Emory University
Keith Delman, MD
Emory University
Paolo Raggi, MD
Emory University
Monica Farley, MD
Emory University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”